Questions with the most recent answer or edit.
For reference: fibrillation · semaglutide · 37 °C. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review…
What I am working with: QSC · mazdutide. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded anything…
The case in front of me: peptide mapping · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit…
The particulars: 97.1% · list of related substances. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
Setup, so nobody has to ask: Suzhou · Norway. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The clinician who ordered the panel was not concerned; I would still like to understand it. The figures are clear enough; the question is what they mean and what they…
For reference: oral semaglutide · 37 °C. I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this.…
The case in front of me: oxidation · tirzepatide · 25 °C. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…
For reference: 97.6% · ecnoglutide · WWB. I am at the decision point and I would rather think it through than improvise. I would rather spend money on measurement…
What I am working with: tirzepatide · three weeks · room temperature. I am at the decision point and I would rather think it through than improvise. I would rather…
Conditions: HbA1c · eGFR · retatrutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that, so I can…
The case in front of me: SURMOUNT-2 · 15 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Numbers first: 98.4% · dulaglutide. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather…
Stated plainly: LDL-C · triglycerides · survodutide. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
What I have: SURMOUNT-3 · 10 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
The case in front of me: semaglutide · four weeks · 25 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and…
The specifics, since they change the answer: dulaglutide · Changsha. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real…
What I have: racemisation · retatrutide · 2–8 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
Conditions: 97.1% · method section. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
Setup, so nobody has to ask: Chengdu · Spain. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
For reference: potassium · ecnoglutide. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles that…
Stated plainly: early satiety · semaglutide · STEP 5. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The case in front of me: SGN · orforglipron. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and…
The specifics, since they change the answer: semaglutide · STEP 4. I have the document in front of me and I can read the numbers. What I cannot do is interpret them.…